Literature DB >> 11852934

Mechanisms of traumatic brain injury: biomechanical, structural and cellular considerations.

A E Davis1.   

Abstract

Traumatic brain injury (TBI) is a public health problem of great concern, because it affects more than 2 million individuals each year. TBI occurs as a result of motor vehicle crashes, falls, and sports-related events. Biomechanical mechanisms occurring at the time of the injury initiate primary and secondary injuries that evolve over several days. In this article the relationship between an blunt injury event and the subsequent damage produced is addressed. Mechanisms of brain injury from biomechanics to cellular pathobiology are presented. Primary and secondary injuries are differentiated, and specific focal and diffuse clinical syndromes are described. Cellular mechanisms responsible for injury are also addressed, because they provide the unifying concepts across the many clinical syndromes so often discussed separately in reviews of traumatic brain injury.

Entities:  

Mesh:

Year:  2000        PMID: 11852934     DOI: 10.1097/00002727-200011000-00002

Source DB:  PubMed          Journal:  Crit Care Nurs Q        ISSN: 0887-9303


  43 in total

Review 1.  Investigational agents for treatment of traumatic brain injury.

Authors:  Ye Xiong; Yanlu Zhang; Asim Mahmood; Michael Chopp
Journal:  Expert Opin Investig Drugs       Date:  2015-03-01       Impact factor: 6.206

2.  Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats.

Authors:  Yuling Meng; Ye Xiong; Asim Mahmood; Yanlu Zhang; Changsheng Qu; Michael Chopp
Journal:  J Neurosurg       Date:  2011-04-15       Impact factor: 5.115

3.  Microwave & Magnetic (M2) Proteomics of a Mouse Model of Mild Traumatic Brain Injury.

Authors:  Teresa M Evans; Holly Van Remmen; Anjali Purkar; Swetha Mahesula; J Al Gelfond; Marian Sabia; Wenbo Qi; Ai-Ling Lin; Carlos A Jaramillo; William E Haskins
Journal:  Transl Proteom       Date:  2014-06-01

4.  Hyperfibrinogenemia-mediated astrocyte activation.

Authors:  Vincent D Clark; Ailey Layson; Mariam Charkviani; Nino Muradashvili; David Lominadze
Journal:  Brain Res       Date:  2018-08-25       Impact factor: 3.252

5.  Treatment of traumatic brain injury with thymosin β₄ in rats.

Authors:  Ye Xiong; Asim Mahmood; Yuling Meng; Yanlu Zhang; Zheng Gang Zhang; Daniel C Morris; Michael Chopp
Journal:  J Neurosurg       Date:  2010-05-21       Impact factor: 5.115

6.  The acute phase of mild traumatic brain injury is characterized by a distance-dependent neuronal hypoactivity.

Authors:  Victoria P A Johnstone; Sandy R Shultz; Edwin B Yan; Terence J O'Brien; Ramesh Rajan
Journal:  J Neurotrauma       Date:  2014-09-11       Impact factor: 5.269

7.  Intracranial injection of recombinant stromal-derived factor-1 alpha (SDF-1α) attenuates traumatic brain injury in rats.

Authors:  Weifeng Sun; Jiafeng Liu; Yu Huan; Chaodong Zhang
Journal:  Inflamm Res       Date:  2013-12-19       Impact factor: 4.575

8.  Inhibition of P2X7 receptors improves outcomes after traumatic brain injury in rats.

Authors:  Xiaofeng Liu; Zhengqing Zhao; Ruihua Ji; Jiao Zhu; Qian-Qian Sui; Gillian E Knight; Geoffrey Burnstock; Cheng He; Hongbin Yuan; Zhenghua Xiang
Journal:  Purinergic Signal       Date:  2017-08-19       Impact factor: 3.765

Review 9.  Animal models of traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Nat Rev Neurosci       Date:  2013-02       Impact factor: 34.870

10.  Tetramethylpyrazine Nitrone Improves Neurobehavioral Functions and Confers Neuroprotection on Rats with Traumatic Brain Injury.

Authors:  Gaoxiao Zhang; Fen Zhang; Tao Zhang; Jianbo Gu; Cuimei Li; Yewei Sun; Pei Yu; Zaijun Zhang; Yuqiang Wang
Journal:  Neurochem Res       Date:  2016-07-25       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.